HEADER OXIDOREDUCTASE 13-JAN-06 2FOI TITLE SYNTHESIS, BIOLOGICAL ACTIVITY, AND X-RAY CRYSTAL STRUCTURAL ANALYSIS TITLE 2 OF DIARYL ETHER INHIBITORS OF MALARIAL ENOYL ACP REDUCTASE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL FRAGMENT, RESIDUES 97-216; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: C-TERMINAL FRAGMENT, RESIDUES 97-156; COMPND 11 EC: 1.3.1.9; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: 3D7; SOURCE 5 GENE: PFENR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODON+-RIL CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 13 ORGANISM_TAXID: 36329; SOURCE 14 STRAIN: 3D7; SOURCE 15 GENE: PFENR; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODON+-RIL CELLS; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ENOYL REDUCTASE, ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.FREUNDLICH,H.SHIEH,J.W.ANDERSON,M.KUO,M.YU,J.VALDERRAMOS, AUTHOR 2 L.KARAGYOZOV,H.TSAI,E.LUCUMI,W.R.JACOBS JR.,G.A.SCHIEHSER, AUTHOR 3 D.P.JACOBUS,D.A.FIDOCK,J.C.SACCHETTINI REVDAT 7 30-AUG-23 2FOI 1 REMARK REVDAT 6 18-OCT-17 2FOI 1 REMARK REVDAT 5 13-JUL-11 2FOI 1 VERSN REVDAT 4 24-FEB-09 2FOI 1 VERSN REVDAT 3 11-SEP-07 2FOI 1 JRNL REVDAT 2 31-JUL-07 2FOI 1 JRNL REVDAT 1 16-JAN-07 2FOI 0 JRNL AUTH J.S.FREUNDLICH,F.WANG,H.C.TSAI,M.KUO,H.M.SHIEH,J.W.ANDERSON, JRNL AUTH 2 L.J.NKRUMAH,J.C.VALDERRAMOS,M.YU,T.R.KUMAR,S.G.VALDERRAMOS, JRNL AUTH 3 W.R.JACOBS,G.A.SCHIEHSER,D.P.JACOBUS,D.A.FIDOCK, JRNL AUTH 4 J.C.SACCHETTINI JRNL TITL X-RAY STRUCTURAL ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL JRNL TITL 2 ACYL CARRIER PROTEIN REDUCTASE AS A PATHWAY TOWARD THE JRNL TITL 3 OPTIMIZATION OF TRICLOSAN ANTIMALARIAL EFFICACY. JRNL REF J.BIOL.CHEM. V. 282 25436 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17567585 JRNL DOI 10.1074/JBC.M701813200 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 23997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1285 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1711 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.87 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 83 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4576 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 134 REMARK 3 SOLVENT ATOMS : 55 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.485 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.289 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.195 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.486 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4808 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6506 ; 1.517 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 574 ; 5.670 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 208 ;39.249 ;24.808 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 852 ;18.427 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;19.701 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 714 ; 0.102 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3568 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2417 ; 0.260 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3379 ; 0.336 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 333 ; 0.202 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 148 ; 0.271 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 25 ; 0.243 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2927 ; 2.819 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4624 ; 4.249 ; 7.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2155 ; 5.888 ; 9.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1882 ; 7.718 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 4 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 97 A 325 4 REMARK 3 1 B 97 B 325 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1807 ; 0.35 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1807 ; 1.18 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 C 366 C 425 4 REMARK 3 1 D 366 D 425 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 C (A): 482 ; 0.24 ; 0.50 REMARK 3 MEDIUM THERMAL 2 C (A**2): 482 ; 1.04 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 3 REMARK 3 CHAIN NAMES : NULL REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 0 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 3 A (A): 44 ; 0.14 ; 0.50 REMARK 3 MEDIUM THERMAL 3 A (A**2): 44 ; 1.41 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 4 REMARK 3 CHAIN NAMES : NULL REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 0 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 4 A (A): 23 ; 0.07 ; 0.50 REMARK 3 MEDIUM THERMAL 4 A (A**2): 23 ; 0.87 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2FOI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000036121. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23997 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 33.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1NHD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.35 M (NH4)2SO4, 100 SODIUM ACETATE REMARK 280 BUFFER, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.34350 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 65.43050 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 65.43050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.01525 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 65.43050 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 65.43050 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.67175 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 65.43050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.43050 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.01525 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 65.43050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.43050 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.67175 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.34350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A TETRAMER GENERATED FROM THE REMARK 300 DIMER IN THE ASYMMETRIC SUBUNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -83.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 37590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -245.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 130.86100 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 130.86100 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.34350 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 326 REMARK 465 ASN A 327 REMARK 465 ASN A 328 REMARK 465 THR A 329 REMARK 465 TYR A 330 REMARK 465 GLU A 331 REMARK 465 ASN A 332 REMARK 465 ASN A 333 REMARK 465 THR A 334 REMARK 465 ASN A 335 REMARK 465 GLN A 336 REMARK 465 ASN A 337 REMARK 465 LYS A 338 REMARK 465 ASN A 339 REMARK 465 ARG A 340 REMARK 465 ASN A 341 REMARK 465 SER A 342 REMARK 465 HIS A 343 REMARK 465 ASP A 344 REMARK 465 VAL A 345 REMARK 465 HIS A 346 REMARK 465 ASN A 347 REMARK 465 ILE A 348 REMARK 465 MET A 349 REMARK 465 ASN A 350 REMARK 465 ASN A 351 REMARK 465 SER A 352 REMARK 465 GLY A 353 REMARK 465 GLU A 354 REMARK 465 LYS A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 LYS A 358 REMARK 465 LYS A 359 REMARK 465 ASN A 360 REMARK 465 SER A 361 REMARK 465 ALA A 362 REMARK 465 SER A 363 REMARK 465 GLN A 364 REMARK 465 ASN A 365 REMARK 465 LEU B 326 REMARK 465 ASN B 327 REMARK 465 ASN B 328 REMARK 465 THR B 329 REMARK 465 TYR B 330 REMARK 465 GLU B 331 REMARK 465 ASN B 332 REMARK 465 ASN B 333 REMARK 465 THR B 334 REMARK 465 ASN B 335 REMARK 465 GLN B 336 REMARK 465 ASN B 337 REMARK 465 LYS B 338 REMARK 465 ASN B 339 REMARK 465 ARG B 340 REMARK 465 ASN B 341 REMARK 465 SER B 342 REMARK 465 HIS B 343 REMARK 465 ASP B 344 REMARK 465 VAL B 345 REMARK 465 HIS B 346 REMARK 465 ASN B 347 REMARK 465 ILE B 348 REMARK 465 MET B 349 REMARK 465 ASN B 350 REMARK 465 ASN B 351 REMARK 465 SER B 352 REMARK 465 GLY B 353 REMARK 465 GLU B 354 REMARK 465 LYS B 355 REMARK 465 GLU B 356 REMARK 465 GLU B 357 REMARK 465 LYS B 358 REMARK 465 LYS B 359 REMARK 465 ASN B 360 REMARK 465 SER B 361 REMARK 465 ALA B 362 REMARK 465 SER B 363 REMARK 465 GLN B 364 REMARK 465 ASN B 365 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 238 CA - CB - CG ANGL. DEV. = -15.5 DEGREES REMARK 500 LEU B 238 CA - CB - CG ANGL. DEV. = -16.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 107 -161.75 -170.20 REMARK 500 ASP A 154 -62.90 -20.16 REMARK 500 LYS A 155 47.47 -63.54 REMARK 500 ASN A 175 36.87 -88.94 REMARK 500 ALA A 219 109.25 -164.48 REMARK 500 SER A 242 -51.40 -123.17 REMARK 500 ILE A 323 -77.66 -57.47 REMARK 500 ASN A 324 105.22 79.63 REMARK 500 ASP B 107 -162.88 -168.33 REMARK 500 LYS B 121 -34.86 -39.83 REMARK 500 ASP B 154 -69.89 -7.18 REMARK 500 LYS B 155 49.80 -42.57 REMARK 500 ASP B 156 33.02 38.36 REMARK 500 ASN B 218 149.08 -170.82 REMARK 500 ALA B 219 115.43 -167.21 REMARK 500 GLN B 259 -1.98 81.16 REMARK 500 THR C 367 175.41 60.09 REMARK 500 ARG C 404 -19.17 -48.22 REMARK 500 ASP C 414 25.01 -154.49 REMARK 500 PHE C 421 -74.16 -96.33 REMARK 500 PRO C 423 175.77 -53.46 REMARK 500 THR D 367 164.63 63.90 REMARK 500 ASP D 414 29.50 -164.85 REMARK 500 PHE D 421 -63.20 -99.06 REMARK 500 PRO D 423 -174.02 -61.31 REMARK 500 ASP D 424 -57.31 -124.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 451 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JPA A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JPA B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NHD RELATED DB: PDB REMARK 900 SAME PROTEIN WITHOUT BOUND INHIBITOR REMARK 900 RELATED ID: 1NHG RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN REMARK 900 RELATED ID: 1NHW RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1NNU RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1ZW1 RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG REMARK 900 RELATED ID: 1ZSN RELATED DB: PDB REMARK 900 SAME PROTEIN BOUND TO TRICLOSAN ANALOG DBREF 2FOI A 97 325 GB 23612231 NP_703811 97 325 DBREF 2FOI B 97 325 GB 23612231 NP_703811 97 325 DBREF 2FOI C 366 425 GB 23612231 NP_703811 366 425 DBREF 2FOI D 366 425 GB 23612231 NP_703811 366 425 SEQRES 1 A 269 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 A 269 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 A 269 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 A 269 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 A 269 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 A 269 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 A 269 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 A 269 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 A 269 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 A 269 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 A 269 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 A 269 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 A 269 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 A 269 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 A 269 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 A 269 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 A 269 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 A 269 ARG ALA ALA THR ALA ILE ASN LYS LEU ASN ASN THR TYR SEQRES 19 A 269 GLU ASN ASN THR ASN GLN ASN LYS ASN ARG ASN SER HIS SEQRES 20 A 269 ASP VAL HIS ASN ILE MET ASN ASN SER GLY GLU LYS GLU SEQRES 21 A 269 GLU LYS LYS ASN SER ALA SER GLN ASN SEQRES 1 B 269 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 B 269 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 B 269 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 B 269 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 B 269 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 B 269 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 B 269 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 B 269 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 B 269 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 B 269 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 B 269 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 B 269 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 B 269 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 B 269 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 B 269 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 B 269 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 B 269 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 B 269 ARG ALA ALA THR ALA ILE ASN LYS LEU ASN ASN THR TYR SEQRES 19 B 269 GLU ASN ASN THR ASN GLN ASN LYS ASN ARG ASN SER HIS SEQRES 20 B 269 ASP VAL HIS ASN ILE MET ASN ASN SER GLY GLU LYS GLU SEQRES 21 B 269 GLU LYS LYS ASN SER ALA SER GLN ASN SEQRES 1 C 60 TYR THR PHE ILE ASP TYR ALA ILE GLU TYR SER GLU LYS SEQRES 2 C 60 TYR ALA PRO LEU ARG GLN LYS LEU LEU SER THR ASP ILE SEQRES 3 C 60 GLY SER VAL ALA SER PHE LEU LEU SER ARG GLU SER ARG SEQRES 4 C 60 ALA ILE THR GLY GLN THR ILE TYR VAL ASP ASN GLY LEU SEQRES 5 C 60 ASN ILE MET PHE LEU PRO ASP ASP SEQRES 1 D 60 TYR THR PHE ILE ASP TYR ALA ILE GLU TYR SER GLU LYS SEQRES 2 D 60 TYR ALA PRO LEU ARG GLN LYS LEU LEU SER THR ASP ILE SEQRES 3 D 60 GLY SER VAL ALA SER PHE LEU LEU SER ARG GLU SER ARG SEQRES 4 D 60 ALA ILE THR GLY GLN THR ILE TYR VAL ASP ASN GLY LEU SEQRES 5 D 60 ASN ILE MET PHE LEU PRO ASP ASP HET NAD A 450 44 HET JPA A 500 23 HET NAD B 451 44 HET JPA B 501 23 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM JPA 4-(2,4-DICHLOROPHENOXY)-2'-METHYLBIPHENYL-3-OL FORMUL 5 NAD 2(C21 H27 N7 O14 P2) FORMUL 6 JPA 2(C19 H14 CL2 O2) FORMUL 9 HOH *55(H2 O) HELIX 1 1 GLY A 110 ARG A 122 1 13 HELIX 2 2 TRP A 131 ASN A 144 1 14 HELIX 3 3 PHE A 147 MET A 151 1 5 HELIX 4 4 THR A 173 ILE A 177 5 5 HELIX 5 5 ASP A 178 ASN A 183 1 6 HELIX 6 6 THR A 194 GLY A 207 1 14 HELIX 7 7 ASP A 225 THR A 229 5 5 HELIX 8 8 SER A 230 SER A 242 1 13 HELIX 9 9 SER A 242 VAL A 253 1 12 HELIX 10 10 TYR A 267 GLN A 271 5 5 HELIX 11 11 GLY A 280 ASN A 304 1 25 HELIX 12 12 SER A 317 ASN A 324 1 8 HELIX 13 13 GLY B 110 ARG B 122 1 13 HELIX 14 14 TRP B 131 PRO B 133 5 3 HELIX 15 15 VAL B 134 ASN B 144 1 11 HELIX 16 16 THR B 173 ILE B 177 5 5 HELIX 17 17 ASP B 178 ASN B 184 1 7 HELIX 18 18 THR B 194 GLY B 207 1 14 HELIX 19 19 ASP B 225 THR B 229 5 5 HELIX 20 20 SER B 230 SER B 242 1 13 HELIX 21 21 SER B 242 VAL B 253 1 12 HELIX 22 22 TYR B 267 GLN B 271 5 5 HELIX 23 23 GLY B 280 ASN B 304 1 25 HELIX 24 24 SER B 317 ALA B 322 1 6 HELIX 25 25 TYR C 366 ALA C 380 1 15 HELIX 26 26 LEU C 387 LEU C 399 1 13 HELIX 27 27 SER C 400 ARG C 404 5 5 HELIX 28 28 GLY C 416 MET C 420 5 5 HELIX 29 29 THR D 367 ALA D 380 1 14 HELIX 30 30 LEU D 387 SER D 400 1 14 HELIX 31 31 ARG D 401 ARG D 404 5 4 HELIX 32 32 GLY D 416 MET D 420 5 5 SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N PHE A 128 O LEU A 165 SHEET 3 A 7 ILE A 99 ALA A 103 1 N ILE A 102 O ILE A 127 SHEET 4 A 7 ILE A 209 HIS A 214 1 O VAL A 213 N ALA A 103 SHEET 5 A 7 MET A 256 THR A 266 1 O ILE A 263 N HIS A 214 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N THR A 266 SHEET 7 A 7 THR C 410 VAL C 413 1 O ILE C 411 N THR A 309 SHEET 1 B 2 ILE A 152 ILE A 153 0 SHEET 2 B 2 LYS A 157 LYS A 158 -1 O LYS A 157 N ILE A 153 SHEET 1 C 7 ILE B 161 PRO B 166 0 SHEET 2 C 7 LYS B 125 ILE B 130 1 N PHE B 128 O LEU B 165 SHEET 3 C 7 ILE B 99 ALA B 103 1 N CYS B 100 O LYS B 125 SHEET 4 C 7 ILE B 209 HIS B 214 1 O VAL B 213 N ALA B 103 SHEET 5 C 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 C 7 ARG B 306 ALA B 312 1 O ILE B 310 N THR B 266 SHEET 7 C 7 THR D 410 VAL D 413 1 O ILE D 411 N THR B 309 SHEET 1 D 2 ILE B 152 ILE B 153 0 SHEET 2 D 2 LYS B 157 LYS B 158 -1 O LYS B 157 N ILE B 153 SITE 1 AC1 26 HOH A 24 HOH A 28 ILE A 105 GLY A 106 SITE 2 AC1 26 GLY A 110 TYR A 111 TRP A 131 PHE A 167 SITE 3 AC1 26 ASP A 168 ALA A 169 SER A 170 SER A 215 SITE 4 AC1 26 LEU A 216 ALA A 217 ASN A 218 LYS A 240 SITE 5 AC1 26 LEU A 265 THR A 266 LYS A 285 ALA A 312 SITE 6 AC1 26 GLY A 313 PRO A 314 LEU A 315 SER A 317 SITE 7 AC1 26 ALA A 319 JPA A 500 SITE 1 AC2 25 GLY B 104 ILE B 105 GLY B 106 GLY B 110 SITE 2 AC2 25 TYR B 111 TRP B 131 PHE B 167 ASP B 168 SITE 3 AC2 25 ALA B 169 SER B 170 SER B 215 LEU B 216 SITE 4 AC2 25 ALA B 217 ASN B 218 LEU B 265 THR B 266 SITE 5 AC2 25 TYR B 267 LYS B 285 ALA B 312 GLY B 313 SITE 6 AC2 25 PRO B 314 LEU B 315 SER B 317 ALA B 319 SITE 7 AC2 25 JPA B 501 SITE 1 AC3 13 ALA A 217 ALA A 219 VAL A 222 TYR A 267 SITE 2 AC3 13 TYR A 277 PRO A 314 ALA A 319 ALA A 320 SITE 3 AC3 13 ILE A 323 NAD A 450 PHE C 368 ILE C 369 SITE 4 AC3 13 ALA C 372 SITE 1 AC4 9 ALA B 217 ALA B 219 TYR B 267 TYR B 277 SITE 2 AC4 9 PRO B 314 ALA B 319 NAD B 451 PHE D 368 SITE 3 AC4 9 ALA D 372 CRYST1 130.861 130.861 82.687 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007642 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007642 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012094 0.00000